Myles David C.
Insider CIK 1831216 · OLMA Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 106,250 | — | $0 | 106,250 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise deriv | 2026-01-14 | 2026-01-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2026-01-14 | 2026-01-14 | 35,003 | $28.99 | $1.01M | 542,761 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2026-01-14 | 2026-01-14 | 14,997 | $28.60 | $428.9K | 577,764 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise | 2026-01-14 | 2026-01-14 | 50,000 | $4.87 | $243.5K | 592,761 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise deriv | 2026-01-13 | 2026-01-14 | 50,000 | — | $0 | 100,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2026-01-13 | 2026-01-14 | 200 | $28.49 | $5.7K | 542,761 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2026-01-13 | 2026-01-14 | 49,800 | $27.60 | $1.37M | 542,961 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise | 2026-01-13 | 2026-01-14 | 50,000 | $4.87 | $243.5K | 592,761 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2026-01-12 | 2026-01-14 | 10,000 | $28.34 | $283.4K | 144,846 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2025-12-19 | 2025-12-23 | 1,225 | $28.08 | $34.4K | 601,656 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2025-12-19 | 2025-12-23 | 43,729 | $30.40 | $1.33M | 557,927 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2025-12-19 | 2025-12-23 | 6,046 | $31.39 | $189.8K | 551,881 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | G Gift | 2025-12-19 | 2025-12-23 | 9,000 | — | $0 | 542,881 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2025-02-28 | 2025-03-03 | 205,000 | — | $0 | 205,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2024-12-11 | 2024-12-11 | 13,314 | $8.66 | $115.3K | 598,633 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2024-12-11 | 2024-12-11 | 300 | $9.39 | $2.8K | 598,333 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2024-12-10 | 2024-12-11 | 12,452 | $9.38 | $116.8K | 611,947 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award | 2024-12-09 | 2024-12-11 | 48,750 | — | $0 | 624,399 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-02-01 | 2024-02-05 | 195,000 | — | $0 | 195,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2023-11-22 | 2023-11-22 | 6,653 | $13.89 | $92.4K | 574,099 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2023-11-21 | 2023-11-22 | 200 | $15.32 | $3.1K | 580,752 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2023-11-21 | 2023-11-22 | 6,776 | $14.87 | $100.8K | 580,952 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award | 2023-11-20 | 2023-11-22 | 26,250 | — | $0 | 587,728 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2023-11-08 | 2023-11-13 | 200 | $17.61 | $3.5K | 561,270 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2023-11-03 | 2023-11-03 | 541 | $17.51 | $9.5K | 561,470 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2023-11-02 | 2023-11-03 | 3,332 | $15.36 | $51.2K | 562,011 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2023-11-01 | 2023-11-03 | 6,668 | $15.02 | $100.2K | 565,343 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2023-09-19 | 2023-09-21 | 20,000 | $12.67 | $253.4K | 572,011 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2023-02-01 | 2023-02-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2022-02-01 | 2022-02-03 | 118,750 | — | $0 | 118,750 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2021-12-10 | 2021-12-14 | 10,000 | $10.30 | $103.0K | 582,901 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-23 | 154,846 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-23 | 12,831 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion | 2020-11-23 | 2020-11-23 | 12,831 | — | $0 | 12,831 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion | 2020-11-23 | 2020-11-23 | 154,846 | — | $0 | 154,846 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-11-18 | 2020-11-19 | 179,340 | — | $0 | 179,340 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award | 2020-06-15 | 2020-11-19 | 143,472 | — | $0 | 591,821 | SEC↗ |